Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Perivascular Macrophages Regulate Blood Flow Following Tissue Damage.
Vågesjö E, Parv K, Ahl D, Seignez C, Herrera Hidalgo C, Giraud A, Leite C, Korsgren O, Wallén H, Juusola G, Hakovirta HH, Rundqvist H, Essand M, Holm L, Johnson RS, Thålin C, Korpisalo P, Christoffersson G, Phillipson M. Vågesjö E, et al. Among authors: korpisalo p. Circ Res. 2021 May 28;128(11):1694-1707. doi: 10.1161/CIRCRESAHA.120.318380. Epub 2021 Apr 21. Circ Res. 2021. PMID: 33878889
Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis.
Rissanen TT, Korpisalo P, Markkanen JE, Liimatainen T, Ordén MR, Kholová I, de Goede A, Heikura T, Gröhn OH, Ylä-Herttuala S. Rissanen TT, et al. Among authors: korpisalo p. Circulation. 2005 Dec 20;112(25):3937-46. doi: 10.1161/CIRCULATIONAHA.105.543124. Epub 2005 Dec 12. Circulation. 2005. PMID: 16344386
Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms.
Lähteenvuo JE, Lähteenvuo MT, Kivelä A, Rosenlew C, Falkevall A, Klar J, Heikura T, Rissanen TT, Vähäkangas E, Korpisalo P, Enholm B, Carmeliet P, Alitalo K, Eriksson U, Ylä-Herttuala S. Lähteenvuo JE, et al. Among authors: korpisalo p. Circulation. 2009 Feb 17;119(6):845-56. doi: 10.1161/CIRCULATIONAHA.108.816454. Epub 2009 Feb 2. Circulation. 2009. PMID: 19188502
Critical limb-threatening ischaemia and microvascular transformation: clinical implications.
Tarvainen S, Wirth G, Juusola G, Hautero O, Kalliokoski K, Sjöros T, Nikulainen V, Taavitsainen J, Hytönen J, Frimodig C, Happonen K, Selander T, Laitinen T, Hakovirta HH, Knuuti J, Laham-Karam N, Hartikainen J, Mäkinen K, Ylä-Herttuala S, Korpisalo P. Tarvainen S, et al. Among authors: korpisalo p. Eur Heart J. 2024 Jan 27;45(4):255-264. doi: 10.1093/eurheartj/ehad562. Eur Heart J. 2024. PMID: 37634134 Free PMC article.
Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogenic vessels.
Korpisalo P, Karvinen H, Rissanen TT, Kilpijoki J, Marjomäki V, Baluk P, McDonald DM, Cao Y, Eriksson U, Alitalo K, Ylä-Herttuala S. Korpisalo P, et al. Circ Res. 2008 Nov 7;103(10):1092-9. doi: 10.1161/CIRCRESAHA.108.182287. Epub 2008 Oct 2. Circ Res. 2008. PMID: 18832750 Free PMC article.
Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation.
Bry M, Kivelä R, Holopainen T, Anisimov A, Tammela T, Soronen J, Silvola J, Saraste A, Jeltsch M, Korpisalo P, Carmeliet P, Lemström KB, Shibuya M, Ylä-Herttuala S, Alhonen L, Mervaala E, Andersson LC, Knuuti J, Alitalo K. Bry M, et al. Among authors: korpisalo p. Circulation. 2010 Oct 26;122(17):1725-33. doi: 10.1161/CIRCULATIONAHA.110.957332. Epub 2010 Oct 11. Circulation. 2010. PMID: 20937974
27 results